Pfizer documents

 

The second batch of Pfizer vaccine documents from the FDA has been released (11,043 pages), as well as an unredacted version of the post-marketing experience report (below).

These documents can be downloaded from http://phmpt.org/pfizers-documents/

(updated 7 April 2022)

 

5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT
REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021

 

reissue_5.3.6-postmarketing-experience

 

 

 

A PHASE 1/2/3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND, DOSE-FINDING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, IMMUNOGENICITY, AND EFFICACY OF SARS-COV-2 RNA VACCINE CANDIDATES AGAINST COVID-19 IN HEALTHY INDIVIDUALS

 

C4591001_Clinical_Protocol_Nov2020_Pfizer_BioNTech

 

 

 

SAFETY DATA SHEET

 

PF00092_MTR_PFEM_EN

 

 

 

CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT
REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021

 

5.3.6-postmarketing-experience

 

error: